Quantcast

Latest HPV Stories

2014-03-13 23:22:41

The Foundation for Women’s Cancer applauds the decision made by an expert panel at the FDA yesterday to include HPV testing as part of first-line primary screening for cervical cancer. The combination of the HPV test and the Pap test can reassure women about their screening results, and is especially important for women over 30 who may be able to extend screening intervals based upon these results. Chicago, IL (PRWEB) March 13, 2014 The Foundation for Women’s Cancer applauds the...

2014-03-12 20:24:30

PLEASANTON, Calif., March 12, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) Microbiology Devices Panel of the Medical Devices Advisory Committee recommended unanimously that the benefits of the cobas® HPV (Human Papillomavirus) Test as a first-line primary screening tool in women 25 years and older to assess their risk of cervical cancer based on the presence of clinically relevant high-risk HPV DNA outweigh...

2014-02-26 04:21:32

KOLKATA, India, February 26, 2014 /PRNewswire/ -- - The careHPV(TM) Test is the first HPV diagnostic designed for regions with limited healthcare infrastructure, complementing QIAGEN's market-leading digene HC2 HPV Test - Commercial launch of careHPV Test in India enables high-quality screening for prevention of cervical cancer among women in low-resource areas - The careHPV Test plays an important role in QIAGEN's...

2014-02-12 08:29:58

ST. PAUL, Minn., Feb. 12, 2014 /PRNewswire-USNewswire/ -- Four leading national medical associations -- the American Academy of Family Physicians (AAFP), the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and American College of Obstetricians and Gynecologists (ACOG) -- together with the Immunization Action Coalition and the Centers for Disease Control and Prevention, have issued a call urging physicians across the U.S. to educate their patients about...

2014-02-10 08:26:48

Report Outlines Recommendations to Overcome Barriers and Support Cancer Prevention Efforts WASHINGTON, Feb. 10, 2014 /PRNewswire-USNewswire/ -- Achieving widespread HPV (human papillomavirus) vaccination is one of the most profound opportunities for cancer prevention, according to a report released today by the President's Cancer Panel. The Panel's report, Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer, issues an urgent call for energizing efforts to reach the HPV...

2014-01-22 11:14:37

Self-testing for Human Papillomavirus (HPV) – the virus that causes cervical cancer – is as effective at detecting cancer as a conventional smear test (cytology screening) even when scaled up to test large populations. Researchers from Queen Mary University of London conducted a pilot study of 100,242 Mexican women – the largest study of its kind – aged 25-75 and from low-income backgrounds. Around 11% of women tested positive for HPV (10,863 women). However, when self-testing...

2014-01-22 10:33:54

The risk of developing cervical cancer can be significantly decreased through human papillomavirus (HPV) vaccination.  Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight...

2014-01-10 11:07:09

A team of scientists at LSU Health Sciences Center New Orleans has discovered the structure of the active form of E6-associated protein (E6AP), an enzyme that acts as a master regulator in the body. They report, for the first time, that the active form of E6AP is composed of three distinct protein molecules. E6AP controls functions as diverse as the ability of nerve cells to "rewire" themselves in response to external stimuli and the mechanism by which certain viruses, like human...

2014-01-08 12:29:02

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:MarketVIEW: HPV therapeutic vaccinesHuman papilloma viruses (HPV) members of the papillomaviridae family are extremely common with an estimated worldwide prevalence of ~11-12%. Although nearly all sexually-active men and women acquire the virus at some point in their lives, most infections are asymptomatic and self-limiting; with 90% clearing within 2 years. High risk forms of HPV (16/18)...


Latest HPV Reference Libraries

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'